Bacterial Battles: How Microbes Fuel the Fire of Acne Inflammation
Acne is a common skin condition that affects millions of people worldwide. While it is often perceived as a superficial issue, acne goes beyond skin deep, involving complex interactions between bacteria, microbes, and the immune system. This article delves into the science behind acne, focusing on the role of bacteria and microbes in triggering inflammation and the development of acne lesions.
The Acne Microbiome: A Battleground of Bacteria
Cutibacterium acnes (C. acnes), once known as Propionibacterium acnes, a bacterium that naturally lives on the skin, has been historically blamed for acne due to its prevalence in affected skin areas. However, in people with acne, an imbalance in the skin microbiome occurs, leading to an overgrowth of C. acnes. The bacteria’s interaction with the skin’s innate immune system through various pathways promotes an inflammatory response [10,11,12,13], central to acne pathology.
C. acnes and Inflammation: A Multifaceted Relationship
C. acnes contributes to inflammatory acne through various mechanisms: [1]
- TLR Activation: C. acnes activates Toll-like receptors (TLRs) on immune cells, leading to the release of pro-inflammatory cytokines like IL-1a, IL-1b, IL-6, and TNF-a, which promote inflammation. [2,3,4]
- Antimicrobial Peptides: The skin produces antimicrobial peptides to fight C. acnes. However, these peptides can also induce inflammation as a byproduct. [8]
- NLRP3 Inflammasome Activation: C. acnes can activate the NLRP3 inflammasome, a protein complex that triggers inflammation. This leads to the release of IL-1b, a potent pro-inflammatory cytokine. [9]
- MMPs and Scarring: C. acnes can induce the production of matrix metalloproteinases (MMPs), which are enzymes that break down collagen and elastin. This can lead to skin damage and scarring. [6]
The Microbiome's Influence on Acne
The skin microbiome is a complex community of microorganisms that live on the skin and play a crucial role in skin health. A disrupted microbiome, characterized by a decrease in beneficial bacteria and an overgrowth of C. acnes, can contribute to inflammatory acne by:
- Promoting Inflammation: Dysbiosis in the skin microbiome can lead to the production of pro-inflammatory cytokines and chemokines, creating an environment that promotes inflammation.
- Impairing Skin Barrier Function: A disrupted microbiome can compromise the skin’s natural barrier function, allowing C. acnes and other harmful bacteria to penetrate deeper into the skin and trigger inflammation.
- Altering Immune Response: The skin microbiome can influence the immune system’s response to C. acnes, promoting inflammation and contributing to the development of acne lesions.
Conclusion:
The interplay between bacteria, microbes, and inflammation plays a pivotal role in the development of acne. Understanding these complex interactions can pave the way for the development of more effective and targeted treatment strategies that focus on restoring the balance of the skin microbiome and mitigating inflammation.
If you wanna dive deeper into
how inflammation ties with
skincare, hit us up on WhatsApp.
Reference:
- Dreno, B., Gollnick, H. P., Kang, S., Thiboutot, D., Bettoli, V., Torres, V., Leyden, J., & Global Alliance to Improve Outcomes in Acne (2015). Understanding innate immunity and inflammation in acne: implications for management. Journal of the European Academy of Dermatology and Venereology : JEADV, 29 Suppl 4, 3–11. https://doi.org/10.1111/jdv.13190
- Kim J. (2005). Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology (Basel, Switzerland), 211(3), 193–198. https://doi.org/10.1159/000087011
- McInturff, J. E., & Kim, J. (2005). The role of toll-like receptors in the pathophysiology of acne. Seminars in cutaneous medicine and surgery, 24(2), 73–78. https://doi.org/10.1016/j.sder.2005.03.002
- Valins, W., Amini, S., & Berman, B. (2010). The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators. The Journal of clinical and aesthetic dermatology, 3(9), 20–29.
- Bernardini, N., Skroza, N., Tolino, E., Mambrin, A., Anzalone, A., Balduzzi, V., Colapietra, D., Marchesiello, A., Michelini, S., Proietti, I., & Potenza, C. (2020). IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art. International journal of dermatology, 59(4), 406–411. https://doi.org/10.1111/ijd.14695
- Mias, C., Mengeaud, V., Bessou-Touya, S., & Duplan, H. (2023). Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway. Journal of the European Academy of Dermatology and Venereology : JEADV, 37 Suppl 2, 3–11. https://doi.org/10.1111/jdv.18794
- Xiao, S., Jin, H., Korn, T., Liu, S. M., Oukka, M., Lim, B., & Kuchroo, V. K. (2008). Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. Journal of immunology (Baltimore, Md. : 1950), 181(4), 2277–2284. https://doi.org/10.4049/jimmunol.181.4.2277
- Jeremy, A. H., Holland, D. B., Roberts, S. G., Thomson, K. F., & Cunliffe, W. J. (2003). Inflammatory events are involved in acne lesion initiation. The Journal of investigative dermatology, 121(1), 20–27. https://doi.org/10.1046/j.1523-1747.2003.12321.x
- Fitz-Gibbon, S., Tomida, S., Chiu, B. H., Nguyen, L., Du, C., Liu, M., Elashoff, D., Erfe, M. C., Loncaric, A., Kim, J., Modlin, R. L., Miller, J. F., Sodergren, E., Craft, N., Weinstock, G. M., & Li, H. (2013). Propionibacterium acnes strain populations in the human skin microbiome associated with acne. The Journal of investigative dermatology, 133(9), 2152–2160. https://doi.org/10.1038/jid.2013.21
- Dagnelie, M. A., Corvec, S., Saint-Jean, M., Nguyen, J. M., Khammari, A., & Dréno, B. (2019). Cutibacterium acnes phylotypes diversity loss: a trigger for skin inflammatory process. Journal of the European Academy of Dermatology and Venereology : JEADV, 33(12), 2340–2348. https://doi.org/10.1111/jdv.15795
- Dagnelie, M. A., Corvec, S., Timon-David, E., Khammari, A., & Dréno, B. (2022). Cutibacterium acnes and Staphylococcus epidermidis: the unmissable modulators of skin inflammatory response. Experimental dermatology, 31(3), 406–412. https://doi.org/10.1111/exd.14467
- Dreno, B., Dekio, I., Baldwin, H., Demessant, A. L., Dagnelie, M. A., Khammari, A., & Corvec, S. (2024). Acne microbiome: From phyla to phylotypes. Journal of the European Academy of Dermatology and Venereology : JEADV, 38(4), 657–664. https://doi.org/10.1111/jdv.19540
- Dréno, B., Dagnelie, M. A., Khammari, A., & Corvec, S. (2020). The Skin Microbiome: A New Actor in Inflammatory Acne. American journal of clinical dermatology, 21(Suppl 1), 18–24. https://doi.org/10.1007/s40257-020-00531-1
